In rodents, the administration of SCFA (in particular, butyrate) prevents diet-induced obesity and the development of diabetes by improving glucose control and insulin sensitivity (Gao et al. 2009). Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.